98 related articles for article (PubMed ID: 10575300)
1. Effects of taurine and vitamin E on microalbuminuria, plasma metalloproteinase-9, and serum type IV collagen concentrations in patients with diabetic nephropathy.
Nakamura T; Ushiyama C; Suzuki S; Shimada N; Ohmuro H; Ebihara I; Koide H
Nephron; 1999; 83(4):361-2. PubMed ID: 10575300
[No Abstract] [Full Text] [Related]
2. Indication of vitamin E on microalbuminuria in patients with incipient diabetic nephropathy.
Yokoyama M; Torita M; Yoshizawa M; Usuda R
Diabetes Metab; 2001 Nov; 27(5 Pt 1):611-2. PubMed ID: 11694862
[No Abstract] [Full Text] [Related]
3. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes.
Hayashi Y; Makino H; Ota Z
Diabet Med; 1992 May; 9(4):366-70. PubMed ID: 1600709
[TBL] [Abstract][Full Text] [Related]
4. Thiamine in diabetic nephropathy: a novel treatment modality?
Alkhalaf A; Kleefstra N; Groenier KH; Bakker SJ; Navis GJ; Bilo HJ
Diabetologia; 2009 Jun; 52(6):1212-3; author reply 1214-6. PubMed ID: 19296076
[No Abstract] [Full Text] [Related]
5. Serum or urinary concentration of type IV collagen in diabetics.
Watanabe T; Negishi K; Katayama S; Ishii J; Kawazu S
J Diabet Complications; 1991; 5(2-3):191-2. PubMed ID: 1770043
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of serum levels of basement membrane components in diabetic patients with and without albuminuria.
Tomono S; Kawazu S; Kato N; Ohno T; Utsugi T; Murata K
J Diabet Complications; 1991; 5(2-3):193-4. PubMed ID: 1770044
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol reduces microalbuminuria in type 2 diabetic nephropathy.
Jiao XM; Jiao XJ; Zhang XG; Xu XP; Wu JX; Yao L; Zhao J; Lü XF
Chin Med J (Engl); 2013 Nov; 126(22):4395-6. PubMed ID: 24238537
[No Abstract] [Full Text] [Related]
8. Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one-step sandwich enzyme immunoassay.
Yagame M; Suzuki D; Jinde K; Saotome N; Sato H; Noguchi M; Sakai H; Kuramoto T; Sekizuka K; Iijima T; Suzuki S; Tomino Y
J Clin Lab Anal; 1997; 11(2):110-6. PubMed ID: 9058245
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria.
Nellemann B; Gormsen LC; Dollerup J; Schmitz O; Mogensen CE; Rasmussen LM; Nielsen S
Diabetes Care; 2007 Dec; 30(12):3122-4. PubMed ID: 17804683
[No Abstract] [Full Text] [Related]
10. Urinary type IV collagen levels in diabetes mellitus.
Sthaneshwar P; Chan SP
Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
[TBL] [Abstract][Full Text] [Related]
11. [Effect of breviscapine on urinary micro-albumine in patients with diabetes mellitus type 2].
Kang SQ; Liu JY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Jun; 23(6):458-9. PubMed ID: 12872404
[No Abstract] [Full Text] [Related]
12. Serum concentrations of basement membrane proteins in NIDDM as a prognostic marker for nephropathy.
Okazaki R; Matsuoka K; Atsumi Y; Maruyama K; Matsuki H; Okazaki I
Diabetes Res Clin Pract; 1995 Jan; 27(1):39-49. PubMed ID: 7781493
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
[TBL] [Abstract][Full Text] [Related]
14. Effect of acarbose on blood glucose and proteinuria in patients with diabetic nephropathy.
Tomino Y; Shirato I; Horikoshi S; Fukui M; Yamaguchi Y; Yokomatsu M; Ebihara I; Shimada N; Hishiki T; Hirano K; Rinno H; Shiota J; Kuramoto T
Nephron; 2000 Jun; 85(2):190. PubMed ID: 10867532
[No Abstract] [Full Text] [Related]
15. Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.
Shen X; Zhang Z; Zhang X; Zhao J; Zhou X; Xu Q; Shang H; Dong J; Liao L
Lipids Health Dis; 2016 Oct; 15(1):179. PubMed ID: 27733168
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
17. Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl)-3, 4-dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in patients with non-insulin dependent diabetes mellitus.
Nishikawa T; Omura M; Iizuka T; Saito I; Yoshida S
Arzneimittelforschung; 1996 Sep; 46(9):875-8. PubMed ID: 8876935
[TBL] [Abstract][Full Text] [Related]
18. Difference of serum levels of type IV collagen 7S between early or overt nephropathy and nondiabetic renal disease in diabetic patients with micro- or macroalbuminuria.
Inomata S; Itoh M; Sato T
Nephron; 1996; 73(4):601-5. PubMed ID: 8856258
[TBL] [Abstract][Full Text] [Related]
19. Oral supplementation with cholecalciferol 800 IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathy.
Huang Y; Yu H; Lu J; Guo K; Zhang L; Bao Y; Chen H; Jia W
PLoS One; 2012; 7(11):e50510. PubMed ID: 23209764
[TBL] [Abstract][Full Text] [Related]
20. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
Banu N; Hara H; Egusa G; Yamakido M
Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
